brij-58 has been researched along with Disease-Models--Animal* in 2 studies
2 other study(ies) available for brij-58 and Disease-Models--Animal
Article | Year |
---|---|
Nanostructures of an amphiphilic zinc phthalocyanine polymer conjugate for photodynamic therapy of psoriasis.
Psoriasis is a chronic inflammatory skin disease affecting 2-5% of the population worldwide and it severely affects patient quality of life. In this study, an amphiphilic zinc phthalocyanine polymer conjugate (ZPB) was synthesized, in which zinc phthalocyanine (ZnPc) was conjugated with the poly(ethylene glycol) (PEG) chain of Brij 58. ZPB showed two maximum UV-vis absorption wavelengths, 348 nm and 678 nm. A monomolecular micelle of ZPB formed in water with a mean size of 25 nm and zeta potential of -15 mV. The nanostructures aggregated into cloudy precipitates, which were easily dispersed. The nanostructure showed the shell-core structure with the ZnPc segments as the core and the PEG chains as the shell. The anti-psoriasis effect of the ZPB nanostructure was explored using a guinea pig psoriasis model. After comparing the anti-psoriasis effects of saline, light alone, ZPB alone, and the combination of light and ZPB, the combination of light and ZPB showed the best photodynamic therapy of psoriasis based on the light excitation of the photosensitizer ZPB and the psoriasis was nearly cured according to the histopathological investigation. The ZPB nanostructure is a promising anti-psoriasis nanomedicine based on photodynamic therapy. Topics: Animals; Cetomacrogol; Disease Models, Animal; Drug Carriers; Guinea Pigs; Humans; Indoles; Isoindoles; Male; Micelles; Nanostructures; Organometallic Compounds; Photochemotherapy; Photosensitizing Agents; Psoriasis; Ultraviolet Rays; Water; Zinc Compounds | 2015 |
Permeation studies of indomethacin from different emulsions for nasal delivery and their possible anti-inflammatory effects.
The purpose of this research was to develop an emulsion formulation of indomethacin (IND) suitable for nasal delivery. IND was incorporated into the oil phases of oil in water (O/W) and water in oil (W/O) emulsions. For this purpose, different emulsifying agents (Tween 80, Span 80 and Brij 58) were used in two emulsion formulations. When the effects of several synthetic membranes (nylon, cellulose, cellulose nitrate) were compared with the sheep nasal mucosa, the cellulose membrane and sheep nasal mucosa showed similar permeation properties for O/W emulsion (P > 0.05). To examine the absorption characteristics of IND, the anti-inflammatory properties of intravenous solution of IND, intranasal O/W emulsions of IND (with or without enhancers) and intranasal solution of IND (IND-Sol) were investigated in rats with carrageenan-induced paw edema. When citric acid was added to the nasal emulsion, the anti-inflammatory activity was similar to that of intravenous solution (P > 0.05). Finally, it was concluded that, intranasal administration of IND emulsion with citric acid may be considered as an alternative to intravenous and per oral administrations of IND to overcome their adverse effects. Topics: Administration, Intranasal; Animals; Anti-Inflammatory Agents, Non-Steroidal; Carrageenan; Cetomacrogol; Chemistry, Pharmaceutical; Citric Acid; Disease Models, Animal; Drug Compounding; Edema; Emulsifying Agents; Emulsions; Hexoses; Indomethacin; Injections, Intravenous; Male; Membranes, Artificial; Nasal Mucosa; Permeability; Polysorbates; Rats; Rats, Wistar; Sheep; Soybean Oil; Time Factors; Water | 2008 |